CSX Transportation today
announced that it has resolved the final stages of its racketeering and fraud
lawsuit against asbestos attorneys Robert N. Peirce Jr. and Louis A. Raimond,
and radiologist Dr. Ray Harron. As part of the settlement, the West Virginia
jury's verdict stands and CSX will be paid $7.3 million to satisfy the trial
court judgment entered against the lawyers and doctor on September 25, 2013,
and in resolution of disputed motions for attorney fees and costs.
CSX brought civil RICO and fraud claims against the defendants on July 5,
2007, alleging that they conspired to manufacture and litigate fraudulent
asbestos claims against the company. In December 2012, a jury agreed and
awarded CSX approximately $429,000 in damages – an amount later tripled to
$1.3 million by the trial court judge as required by the federal racketeering
statute. Those damages and legal fees totaled $7.3 million.
Prior to this settlement, the judgment had been on appeal to the United States
Court of Appeals for the Fourth Circuit in Richmond, Va. That appeal is to be
dismissed, leaving the jury's findings and resulting judgment undisturbed.
"We sincerely thank the jury and the judges. They acknowledged that fraud in
injury claims degrades the U.S. system and makes it harder for truly injured
persons to be treated fairly," said Ellen M. Fitzsimmons, executive vice
president, law and public affairs, CSX. "These funds will be donated to the
CSX Foundation, where they will be dedicated to philanthropic efforts serving
CSX's communities."
The CSX Foundation supports Beyond our Rails (beyondourrails.org), a shared
effort between CSX and its employees to advance safety, wellness,
environmental and community-based initiatives that seek to improve the
well-being of the people and places CSX serves.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in